Nutra Pharma delays Q2 10-Q filing, citing need for more time to finalize financials - NPHC News | RalliesNutra Pharma delays Q2 10-Q filing, citing need for more time to finalize financials
N
NPHC• Late filing notice for second-quarter report
- Nutra Pharma filed a Form 12b-25 to delay its Form 10-Q for the quarter ended June 30, 2026.
- Management cited the need for more time with auditors to prepare financial information for the quarterly report.
- The filing targets submission within five calendar days of the original due date.
- The notice flagged no expected significant change in results from the comparable prior-year period.
- The late-filing notification was signed Aug. 14, 2026.
